SCHOTT Pharma AG & Co. KGaA (1SXP) — Capital Reinvestment Ratio
Latest as of September 2024:
0.85x
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Capital Reinvestment Ratio of 0.85x as of September 2024, meaning it reinvests 1% of its operating cash flow (€75.97 Million) in capital expenditures (€64.68 Million). See 1SXP FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.85x
Capex / Operating Cash Flow
Operating Cash Flow
€75.97 Million
EUR
Capital Expenditures
€64.68 Million
EUR
Data as of
Sep 2024
Most recent filing
SCHOTT Pharma AG & Co. KGaA Capital Reinvestment Ratio (2020–2024)
This chart tracks SCHOTT Pharma AG & Co. KGaA's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for SCHOTT Pharma AG & Co. KGaA (2020–2024)
Year-by-year Capital Reinvestment Ratio for SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. For live market cap and broader valuation context, see SCHOTT Pharma AG & Co. KGaA stock valuation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.64x | €225.33 Million | €145.30 Million | ▼ -33.3% |
| 2023 | 0.97x | €181.65 Million | €175.52 Million | ▲ +15.3% |
| 2022 | 0.84x | €182.12 Million | €152.69 Million | ▲ +12.4% |
| 2021 | 0.75x | €132.21 Million | €98.63 Million | ▼ -8.7% |
| 2020 | 0.82x | €104.40 Million | €85.31 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow